Koethe JR, Jenkins CA, Lau B, Shepherd BE, Justice AC, Tate JP, Buchacz K, Napravnik S, Mayor AM, Horberg MA, et al. Rising obesity prevalence and weight gain among adults starting antiretroviral therapy in the United States and Canada. AIDS Res Hum Retroviruses. 2016;32:50–8. https://doi.org/10.1089/aid.2015.0147.

Article  PubMed  PubMed Central  Google Scholar 

•• Sax PE, Erlandson KM, Lake JE, McComsey GA, Orkin C, Esser S, Brown TT, Rockstroh JK, Wei X, Carter CC, et al. Weight gain following initiation of antiretroviral therapy: risk factors in randomized comparative clinical trials. Clin Infect Dis. 2020;71:1379–89. https://doi.org/10.1093/cid/ciz999. Pooled Analysis of ART-associated weight gain in ART naïve patients starting therapy.

Article  CAS  PubMed  Google Scholar 

Bourgi K, Jenkins CA, Rebeiro PF, Palella F, Moore RD, Altoff KN, Gill J, Rabkin CS, Gange SJ, Horberg MA, et al. Weight gain among treatment-naive persons with HIV starting integrase inhibitors compared to non-nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada. J Int AIDS Soc. 2020;23:e25484. https://doi.org/10.1002/jia2.25484.

Article  PubMed  PubMed Central  Google Scholar 

Duncan AD, Goff LM, Peters BS. Type 2 diabetes prevalence and its risk factors in HIV: a cross-sectional study. PLoS ONE. 2018;13:e0194199. https://doi.org/10.1371/journal.pone.0194199.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hernandez-Romieu AC, Garg S, Rosenberg ES, Thompson-Paul AM, Skarbinski J. Is diabetes prevalence higher among HIV-infected individuals compared with the general population? Evidence from MMP and NHANES 2009–2010. BMJ Open Diabetes Res Care. 2017;5:e000304. https://doi.org/10.1136/bmjdrc-2016-000304.

Article  PubMed  PubMed Central  Google Scholar 

Worm SW, De Wit S, Weber R, Sabin CA, Reiss P, El-Sadr W, Monforte AD, Kirk O, Fontas E, Dabis F, et al. Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A: D Study). Circulation. 2009;119:805–11. https://doi.org/10.1161/CIRCULATIONAHA.108.790857.

Article  PubMed  PubMed Central  Google Scholar 

Putcharoen O, Wattanachanya L, Sophonphan J, Siwamogsatham S, Sapsirisavat V, Gatechompol S, Phonphithak S, Kerr SJ, Chattranukulchai P, Avihingsanon Y, et al. New-onset diabetes in HIV-treated adults: predictors, long-term renal and cardiovascular outcomes. AIDS. 2017;31:1535–43. https://doi.org/10.1097/QAD.0000000000001496.

Article  PubMed  Google Scholar 

McCutchan JA, Marquie-Beck JA, Fitzsimons CA, Letendre SL, Ellis RJ, Heaton RK, Wolfson T, Rosario D, Alexander TJ, Marra C, et al. Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder. Neurology. 2012;78:485–92. https://doi.org/10.1212/WNL.0b013e3182478d64.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nansseu JR, Bigna JJ, Kaze AD, Noubiap JJ. Incidence and risk factors for prediabetes and diabetes mellitus among HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysis. Epidemiol. 2018;29:431–41. https://doi.org/10.1097/EDE.0000000000000815.

Article  Google Scholar 

McMahon CN, Petoumenos K, Hesse K, Carr A, Cooper DA, Samaras K. High rates of incident diabetes and prediabetes are evident in men with treated HIV followed for 11 years. AIDS. 2018;32:451–9. https://doi.org/10.1097/QAD.0000000000001709.

Article  PubMed  Google Scholar 

Slama L, Barrett BW, Abraham AG, Palella FJ Jr, Kingsley L, Viard JP, Lake JE, Brown TT, Multicenter ACS. risk for incident diabetes is greater in prediabetic men with HIV than without HIV. AIDS. 2021;35:1605–14. https://doi.org/10.1097/QAD.0000000000002922.

Article  PubMed  Google Scholar 

Yuh B, Tate J, Butt AA, Crothers K, Freiberg M, Leaf D, Logeais M, Rimland D, Rodriguez-Barradas MC, Ruser C, et al. Weight change after antiretroviral therapy and mortality. Clin Infect Dis. 2015;60:1852–9. https://doi.org/10.1093/cid/civ192.

Article  PubMed  PubMed Central  Google Scholar 

Herrin M, Tate JP, Akgun KM, Butt AA, Crothers K, Freiberg MS, Gibert CL, Leaf DA, Rimland D, Rodriguez-Barradas MC, et al. Weight gain and incident diabetes among HIV-infected veterans initiating antiretroviral therapy compared with uninfected individuals. J Acquir Immune Defic Syndr. 2016;73:228–36. https://doi.org/10.1097/QAI.0000000000001071.

Article  CAS  PubMed  PubMed Central  Google Scholar 

•• Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, McGowan BM, Rosenstock J, Tran MTD, Wadden TA, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384:989–1002. https://doi.org/10.1056/NEJMoa2032183. Recent randomized controlled trial that demonstrated efficacy of Semaglutide as a weight loss agent. 

Article  CAS  PubMed  Google Scholar 

•• Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387:205. https://doi.org/10.1056/NEJMoa2206038. Recent randomized controlled trial that demonstrated efficacy of tirzepatide as a weight loss agent.

Article  CAS  PubMed  Google Scholar 

Grunfeld C, Feingold KR. Metabolic disturbances and wasting in the acquired immunodeficiency syndrome. N Engl J Med. 1992;327:329–37. https://doi.org/10.1056/NEJM199207303270506.

Article  CAS  PubMed  Google Scholar 

Macallan DC, McNurlan MA, Milne E, Calder AG, Garlick PJ, Griffin GE. Whole-body protein turnover from leucine kinetics and the response to nutrition in human immunodeficiency virus infection. Am J Clin Nutr. 1995;61:818–26. https://doi.org/10.1093/ajcn/61.4.818.

Article  CAS  PubMed  Google Scholar 

Rasmussen LD, Mathiesen ER, Kronborg G, Pedersen C, Gerstoft J, Obel N. Risk of diabetes mellitus in persons with and without HIV: a Danish nationwide population-based cohort study. PLoS ONE. 2012;7:e44575. https://doi.org/10.1371/journal.pone.0044575.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brown TT, Cole SR, Li X, Kingsley LA, Palella FJ, Riddler SA, Visscher BR, Margolick JB, Dobs AS. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med. 2005;165:1179–84. https://doi.org/10.1001/archinte.165.10.1179.

Article  PubMed  Google Scholar 

Capeau J, Bouteloup V, Katlama C, Bastard JP, Guiyedi V, Salmon-Ceron D, Protopopescu C, Leport C, Raffi F, Chene G, et al. Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment. AIDS. 2012;26:303–14. https://doi.org/10.1097/QAD.0b013e32834e8776.

Article  CAS  PubMed  Google Scholar 

Hogh J, Gelpi M, Hove-Skovsgaard M, Afzal S, Nordestgaard BG, Gerstoft J, Benfield T, Storgaard H, Nielsen SD. HIV infection is associated with type 2 diabetes mellitus. J Acquir Immune Defic Syndr. 2021;88:e32–5. https://doi.org/10.1097/QAI.0000000000002798.

Article  CAS  PubMed  Google Scholar 

International Expert C. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009;32:1327–34. https://doi.org/10.2337/dc09-9033.

Article  CAS  Google Scholar 

American Diabetes Association Professional Practice C: 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022. Diabetes Care. 2022;45:S17–38. https://doi.org/10.2337/dc22-S002.

Article  Google Scholar 

Slama L, Palella FJ Jr, Abraham AG, Li X, Vigouroux C, Pialoux G, Kingsley L, Lake JE, Brown TT. Inaccuracy of haemoglobin A1c among HIV-infected men: effects of CD4 cell count, antiretroviral therapies and haematological parameters. J Antimicrob Chemother. 2014;69:3360–7. https://doi.org/10.1093/jac/dku295.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim PS, Woods C, Georgoff P, Crum D, Rosenberg A, Smith M, Hadigan C. A1C underestimates glycemia in HIV infection. Diabetes Care. 2009;32:1591–3. https://doi.org/10.2337/dc09-0177.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eckhardt BJ, Holzman RS, Kwan CK, Baghdadi J, Aberg JA. Glycated hemoglobin A(1c) as screening for diabetes mellitus in HIV-infected individuals. AIDS Patient Care STDS. 2012;26:197–201. https://doi.org/10.1089/apc.2011.0379.

Article  PubMed  PubMed Central  Google Scholar 

Monroe AK, Glesby MJ, Brown TT. Diagnosing and managing diabetes in HIV-infected patients: current concepts. Clin Infect Dis. 2015;60:453–62. https://doi.org/10.1093/cid/ciu779.

Article  CAS  PubMed  Google Scholar 

Butt AA, McGinnis K, Rodriguez-Barradas MC, Crystal S, Simberkoff M, Goetz MB, Leaf D, Justice AC. Veterans Aging Cohort S: HIV infection and the risk of diabetes mellitus. AIDS. 2009;23:1227–34. https://doi.org/10.1097/QAD.0b013e32832bd7af.

Article  PubMed  Google Scholar 

Tien PC, Schneider MF, Cole SR, Levine AM, Cohen M, DeHovitz J, Young M, Justman JE. Antiretroviral therapy exposure and incidence of diabetes mellitus in the Women’s Interagency HIV Study. AIDS. 2007;21:1739–45. https://doi.org/10.1097/QAD.0b013e32827038d0.

Article  CAS  PubMed  Google Scholar 

Grunfeld C, Saag M, Cofrancesco J Jr, Lewis CE, Kronmal R, Heymsfield S, Tien PC, Bacchetti P, Shlipak M, Scherzer R, et al. Regional adipose tissue measured by MRI over 5 years in HIV-infected and control participants indicates persistence of HIV-associated lipoatrophy. AIDS. 2010;24:1717–26. https://doi.org/10.1097/QAD.0b013e32833ac7a2.

Article  PubMed  Google Scholar 

Neuhaus J, Jacobs DR Jr, Baker JV, Calmy A, Duprez D, La Rosa A, Kuller LH, Pett SL, Ristola M, Ross MJ, et al. Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis. 2010;201:1788–95. https://doi.org/10.1086/652749.

Article  CAS  PubMed  Google Scholar 

Brown TT, Tassiopoulos K, Bosch RJ, Shikuma C, McComsey GA. Association between systemic inflammation and incident diabetes in HIV-infected patients after initiation of antiretroviral therapy. Diabetes Care. 2010;33:2244–9. https://doi.org/10.2337/dc10-0633.

Article  PubMed  PubMed Central  Google Scholar 

Betene ADC, De Wit S, Neuhaus J, Palfreeman A, Pepe R, Pankow JS, Neaton JD, Insight S, Groups ES. Interleukin-6, high sensitivity C-reactive protein, and the development of type 2 diabetes among HIV-positive patients taking antiretroviral therapy. J Acquir Immune Defic Syndr. 2014;67:538–46. https://doi.org/10.1097/QAI.0000000000000354.

Article